Reynolds Cameron John bought VNRX
March 26, 2025 · Form 4 insider transaction
Reynolds Cameron John bought 181,818 shares of VolitionRx Limited at $0.55 per share, a transaction worth $100.0K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4.
Direction
Acquired (buy-side)
Shares
181,818
Price
$0.55
Total value
$100.0K
InsiderReynolds Cameron John
RoleOfficer, Director
CompanyVolitionRx Limited (VNRX)
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateMarch 26, 2025
Filing dateMarch 27, 2025
Shares owned after2,299,222
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Acquired at the offering price in the registered direct offering of Common Stock by VolitionRx.